Clinical Trial

The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-05-02; most recent amendment 2025-05-14.
Status change: Recruiting → Active, Not Recruiting 2023-03-15
Status change: Not Yet Recruiting → Recruiting 2017-06-05
Trial Details
NCT Number NCT03140358
Lead Sponsor Singapore National Eye Centre
Collaborators: National Medical Research Council (NMRC), Singapore
Conditions Myopia
Enrollment 300 participants
Start Date 2017-04-21
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-18